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During a 4.5-year period, 5 patients underwent reresection of colorectal liver metastases. Two patients
died of recurrent disease, 9-11 months after reresection. Three patients are alive, one without and two
with recurrent disease, 15, 15 and 68 months after reresection. Although our results suggest that liver
reresection may be meaningful in selected patients with colorectal liver metastases, further studies are
necessary in order to define candidates for this procedure.
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INTRODUCTION
Liver resection gives 5-year survival rates of about 30% in both primary colorectal
and primary liver cancer1’2. Except for dearterialization procedures for carcinoid
liver disease, and liver transplantation for primary liver cancer3’4, no other treat-
ment has been demonstrated to achieve cure or long-term palliation in malignant
liver disease.
Treatment of recurrent cancer after liver resection is usually palliative and may
include chemotherapy. Relapse after resection of colorectal liver metastases is
usually not confined to a single site; the liver, lungs and peritoneal cavity being the
most common sites of first recurrence. It appears, however, that about 1/3 of
patients with relapse have (the initial) relapse in the liver alone, indicating a role
for repeat liver resection in selected patients5.
This paper reports our preliminary experience of reresection of colorectal liver
metastases and tries to answer whether continued evaluation of such aggressive
efforts is justified.
PATIENTS
From July 1983 to December 1987, 5 patients, 2 female and 3 male, underwent
reresection of colorectal liver cancer. The mean age at reresection was 57 (range:
44-70) years. Synchronous metastatic disease in the liver was detected at the
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primary abdominoperineal resection for rectal carcinoma (Dukes C) in 1 patient
and at left hemicolectomy (Dukes C) in 1; metachronous disease was detected 4
months, 1 year and 4 years after left hemicolectomy for sigmoid carcinoma (Dukes
C, C and A, respectively) (Table 1).
Table 1 Patients.
Patient Primary Age Sex 1st liver resection
no. tumor (atresection)
y months
after no. of type of
primary op metastases operation
rectal cancer 70 M 3 right lobectomy
(Dukes C)
2 sigmoid cancer 44 M 12 right lobectomy
(Dukes C)
3 sigmoid cancer 61 F 48 1 right lobectomy
(Dukes A)
4 sigmoid cancer 51 F 2 resection of quadrate lobe
(Dukes C)
5 sigmoid cancer 62 M 4 right iobectomy
A solitary liver deposit was removed by right hepatectomy in 4 patients, 3-48
months after the primary operation, and by resection of the quadrate lobe in 1
patient, 2 months after the primary operation. Resection margins were free of
tumour in all resected specimens. Intraoperative ultrasonography was not avail-
able.
RERESECTION OF THE LIVER
Recurrent disease in the liver was asymptomatic and detected at routine follow-up
that included physical examination, liver function tests and computed tomography.
The interval between the first and second liver resections varied between 4 and 37
months with a median interval of 6 months (Table 2).
Wedge resections or larger, "atypical", resections were performed in all patients.
The number of liver secondaries varied from 1-10; three patients had single wedge
or atypical resections and two patients had an atypical resection combined with a
wedge resection or resection of the caudate lobe.
RESULTS
The results are summarized in Table 2. Three patients are alive; one of them has no
evidence of disease 15 months after reresection (as estimated by liver function tests,
carcinoembryonic antigen levels, pulmonary x-ray and ultrasound of the liver); the
other two patients have relapse in the lungs (both patients) and the liver (one
patient) at 15 and 68 months after reresection. Two patients died of recurrent
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disease, in the liver or skeleton, 9 and 11 months after reresection. The (cumulat-
ive) number of liver metastases appeared to have prognostic significance: of the two
patients with a solitary metastasis at both liver resections, one is alive without
evidence of disease whereas the other has survived for 68 months after reresection
but with evidence of relapse in the liver and the lungs.
Postoperatively, one patient had a subhepatic abscess requiring surgical
drainage.
Table 2 Reresection of liver metastases.
Patient no. Months after 1st No. of
liver resection metastases
Type of re- Morbidity Recurrence
section
4 10
2 37 2
3 5
4 7
5 6 3
LWD living with disease
NED no evidence of disease
Atypical
Atypical Subhepatic
+ wedge abscess
Atypical
Wedge
Atypical
+ caudate
lobe
Survival
(after rere-
section),
mo
liver, peritoneal 11
cavity
skeleton 9
liver, lungs 68(LWD)
0 15(NED)
lungs 15(LWD)
DISCUSSION
Information about the value of reresection of liver cancer is scanty and can be
found only in a few recent reports. As for hepatocellular carcinoma, Nagasue et al.
and Kanematsu et al. reported that a second hepatic resection was followed by
meaningful palliation in some patients and, probably, survival benefit in a few6’7.
As for liver metastases, Nordlinger et al. reported the fate of 6 patients having
undergone reresection for colorectal liver cancer: 2 patients were alive without
evidence of disease after 2 and 12 months, 3 patients were alive with recurrent
disease after 14, 16 and 28 months, and 1 patient died 10 months following
reresection8. A similar experience was reported also by Fortner9.
In our study, it appears that the two patients with more than one deposit at
reresection did not benefit from the procedure. On the other hand, it appears likely
that reresection was beneficial in the two patients having single deposits at both the
first and second liver resection and thus a cumulative number of 2 liver tumours.
For colorectal cancer, previous studies have indicated that (a first) liver resection
is indicated when (a) the number of liver tumors is 3 or less, (b), extrahepatic tumor
is not demonstrable, and (c) a resection margin of at least 10 mm can be
10 11obtained Although the review of the literature and our own results indicate that
few patients benefit from reresection of colorectal liver secondaries, our data
suggest that reresection is worth a try in patients having a cumulative number of 2
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liver metastases. However, further experience is needed for proper definition of
reresection criteria.
The fact that four of the five patients have developed recurrent disease (hepatic
recurrence in 2) emphasizes the inadequacy of presently available diagnostic
methods (Table 2). Since 4 patients developed hepatic relapse within 7 months
after the first liver resection, it should be noted that these recurrences did not occur
at the site of the initial resection but were missed at the first operation. Anyhow,
these early recurrences suggest that intraoperative ultrasonography should have
been helpful in detecting these "occult" metastases at the first hepatic resection.
The use of iatraoperative ultrasonography, now available at our and other centres,
would lead to a better selection of patients for liver resection and, possibly,
improved criteria for liver (re)resection.
Since the two patients with hepatic recurrence also had extrahepatic relapse,
none of them would have been helped with liver transplantation. At any rate, the
dismal experience with liver transplantation for "isolated" colorectal liver
cancer4’12’13 contraindicates liver grafting in patients with colorectal liver metas-
tases.
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